Wells Fargo & Company Iqvia Holdings Inc. Put Options Transaction History

Wells Fargo & Company

7 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2024 May 10, 2024	SELL	$208.23 - $259.1 $1.04 Million - $1.3 Million	-5,000 Reduced 0.94%	525,000 $133 Million
Q4 2023 Feb 09, 2024	BUY	$177.16 - $232.73 $93.9 Million - $123 Million	530,000 New	530,000 $123 Million
Q2 2022 Aug 12, 2022	BUY	$196.45 - $252.29 $12.5 Million - $16 Million	63,500 Added 384.85%	80,000 $17.4 Million
Q4 2020 Feb 09, 2021	SELL	$153.99 - $180.39 $2.85 Million - $3.34 Million	-18,500 Reduced 52.86%	16,500 $94,000
Q3 2020 Nov 05, 2020	BUY	$141.28 - $169.75 $706,400 - $848,750	5,000 Added 16.67%	35,000 $71,000

Q2 2020 Aug 13, 2020	SELL	$100.04 - $153.06 $10 Million - $15.4 Million	-100,300 Reduced 76.98%	30,000 $85,000
Q1 2020 May 14, 2020	BUY	$84.0 - $166.11 $10.9 Million - $21.6 Million	130,300 New	130,300 $3.41 Million

1,084

155M

318K

951K

Ticker IQV
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 185,740,000
Market Cap $38.7B
Description
IQVIA Holdings Inc. provides advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The ...

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

Stay updated on Wells Fargo & Company with notifications on news.